HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuro Oshika Selected Research

Capsule Opacification

5/2020Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate.
5/2016Surgical outcomes of congenital and developmental cataracts in Japan.
5/2009Intraindividual comparison of aspherical and spherical intraocular lenses of same material and platform.
1/2007Posterior capsule opacification after combined cataract surgery and vitrectomy.
4/2006Prospective intrapatient comparison of 6.0-millimeter optic single-piece and 3-piece hydrophobic acrylic foldable intraocular lenses.
7/2004Relationship between anterior capsule contraction and posterior capsule opacification after cataract surgery in patients with diabetes mellitus.
4/2004Limitation of Scheimpflug videophotography system in quantifying posterior capsule opacification after intraocular lens implantation.
2/2004Migration of lens epithelial cells through haptic root of single-piece acrylic-foldable intraocular lens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuro Oshika Research Topics

Disease

38Cataract (Cataracts)
03/2024 - 01/2002
22Myopia
12/2023 - 07/2002
20Astigmatism
12/2023 - 02/2002
13Retinal Detachment (Retinal Detachments)
09/2021 - 01/2006
12Retinal Perforations
01/2024 - 01/2012
12Retinal Vein Occlusion
02/2023 - 06/2017
11Epiretinal Membrane (Epiretinal Membranes)
03/2023 - 05/2009
11Vision Disorders (Hemeralopia)
10/2022 - 05/2009
9Glaucoma
12/2023 - 03/2003
9Keratoconus
07/2022 - 02/2002
9Blister (Bulla)
01/2018 - 01/2005
8Aniseikonia
07/2022 - 07/2014
8Capsule Opacification
05/2020 - 02/2004
8Diabetic Retinopathy (Retinopathy, Diabetic)
12/2016 - 01/2002
7Refractive Errors (Refractive Error)
12/2023 - 03/2003
7Coma (Comas)
07/2013 - 09/2002
6Macular Edema
10/2022 - 07/2014
6Wounds and Injuries (Trauma)
04/2019 - 03/2007
6Diabetes Mellitus
01/2007 - 01/2002
5Retinopathy of Prematurity (Retrolental Fibroplasia)
12/2023 - 12/2016
5Ganglion Cysts (Ganglion)
07/2023 - 10/2012
5Keratitis
08/2012 - 12/2003
4Macular Degeneration (Age-Related Maculopathy)
10/2021 - 06/2010
4Blindness (Hysterical Blindness)
01/2021 - 01/2006
4Inflammation (Inflammations)
05/2015 - 11/2003
4Rupture
07/2009 - 07/2004
3Geographic Atrophy
10/2021 - 01/2018
3Vitreous Hemorrhage
11/2019 - 03/2014
3Fibrosis (Cirrhosis)
01/2018 - 05/2014
3Uveitis
01/2015 - 11/2003
3Edema (Dropsy)
04/2009 - 06/2002
2Dry Eye Syndromes (Dry Eye Syndrome)
03/2024 - 11/2021
2Endophthalmitis (Ophthalmia)
01/2022 - 12/2007
2Cicatrix (Scar)
01/2018 - 05/2016
2Cysts
11/2016 - 03/2010
2Pseudophakia
05/2016 - 08/2014
2Hereditary Corneal Dystrophies
05/2015 - 08/2013
2Hemorrhage
09/2014 - 05/2003
2Infections
11/2013 - 03/2003
2Retinitis Pigmentosa (Pigmentary Retinopathy)
10/2013 - 11/2003
2Hypertension (High Blood Pressure)
04/2011 - 08/2010

Drug/Important Bio-Agent (IBA)

32Retinaldehyde (Retinal)IBA
10/2021 - 09/2002
11Ranibizumab (Lucentis)FDA Link
02/2023 - 01/2018
11Capsules (Microcapsules)IBA
05/2021 - 01/2002
10Ophthalmic Solutions (Eye Drops)IBA
03/2024 - 03/2003
6Proteins (Proteins, Gene)FDA Link
12/2015 - 01/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 01/2006
4HydrogelsIBA
11/2019 - 04/2004
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2019 - 07/2015
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015 - 11/2003
4Hyaluronic Acid (Hyaluronan)IBA
03/2010 - 02/2004
4SuspensionsIBA
07/2009 - 07/2004
3Bevacizumab (Avastin)FDA Link
09/2021 - 07/2014
3SteroidsIBA
12/2018 - 07/2004
3SolutionsIBA
12/2018 - 03/2007
3Mydriatics (Cycloplegics)IBA
09/2018 - 08/2010
3SiliconesIBA
02/2018 - 04/2004
3Indicators and Reagents (Reagents)IBA
10/2015 - 02/2002
3Peptides (Polypeptides)IBA
08/2013 - 01/2006
3Advanced Glycation End ProductsIBA
08/2012 - 06/2005
3CholesterolIBA
04/2011 - 02/2008
3Cortodoxone (11 Deoxycortisol)IBA
02/2008 - 07/2004
2Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2024 - 01/2015
2diquafosolIBA
03/2024 - 11/2021
2Fluorescein (Funduscein)FDA LinkGeneric
03/2024 - 12/2016
2Timolol (Blocadren)FDA LinkGeneric
07/2023 - 12/2003
2AtropineFDA LinkGeneric
04/2023 - 05/2021
2Complementary DNA (cDNA)IBA
10/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2018
2SaltsIBA
12/2018 - 07/2015
24-hexyloxyaniline (HOA)IBA
11/2017 - 06/2004
2CollagenIBA
05/2016 - 02/2013
2Aspartic Acid (Aspartate)FDA Link
12/2015 - 08/2012
2Amyloid (Amyloid Fibrils)IBA
08/2013 - 08/2012

Therapy/Procedure

27Intraocular Lenses (Intraocular Lens)
03/2024 - 07/2002
27Vitrectomy
01/2024 - 07/2004
12Phacoemulsification
03/2023 - 07/2002
11Lasers (Laser)
12/2023 - 08/2003
10Therapeutics
12/2023 - 06/2002
10Aftercare (After-Treatment)
07/2022 - 12/2006
10Laser In Situ Keratomileusis (LASIK)
04/2006 - 08/2003
9Intraocular Lens Implantation
12/2023 - 04/2004
7Contact Lenses
04/2023 - 06/2002
7Trabeculectomy (Trabeculoplasty)
01/2018 - 05/2003
5Laser Therapy (Surgery, Laser)
12/2023 - 07/2002
5Intravitreal Injections
02/2023 - 07/2014
5Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
07/2022 - 06/2005
5Sutures (Suture)
01/2022 - 04/2002
5Light Coagulation
09/2021 - 01/2002
4Slit Lamp
01/2024 - 09/2003
4Injections
01/2023 - 01/2019
4Operative Surgical Procedures
08/2014 - 10/2005
4Penetrating Keratoplasty
03/2005 - 04/2002
3Capsulorhexis
12/2023 - 07/2002
3Lenses
09/2018 - 03/2005
3Eyeglasses (Spectacles)
01/2018 - 04/2011
3Filtering Surgery
11/2016 - 05/2003
3Photorefractive Keratectomy
09/2006 - 03/2004
2Posterior Capsulotomy
05/2016 - 07/2015
2Corneal Transplantation (Keratoplasty)
05/2015 - 08/2011